-
Validation of CD4 T Cell Dependent Neurotoxicity in an Alpha-Synuclein Model of Parkinson's Disease
… their way through clinical trials for disorders including multiple sclerosis. It is important to assess whether …
-
Current and projected future economic burden of Parkinson's disease in the U.S
June 2, 2020
… the U.S. (2017) and projections for the next two decades. Multiple data sources were used to estimate the costs of PD, …
-
Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients
November 13, 2020
… PD patient plasma for evidence of inflammasome activity. Multiple circulating inflammasome proteins were detected …
-
Validation of RRx-001 as a Novel Disease-modifying Therapeutic for Parkinson's Disease
… Study Design: We will test the effectiveness of RRx-001 in multiple pre-clinical models of Parkinson’s disease and also …
-
Genetics and Parkinson’s: Understanding the Role of Gene Therapy in a Cure (Webinar Audio)
July 26, 2023
… Parkinson’s, and her husband, Rich Sussman, who have joined multiple studies and considered a trial of Parkinson’s gene …
-
Development of Autophagy-lysosome Biomarkers for Parkinson’s Disease Using Stem Cell-derived Neurons and Biofluids
… application. Hypothesis: We hypothesize that through our systematic search and development, we will be able to … samples and test the sensitivity of the immunoassays in multiple types of human biofluid. …